Analysts blame worries about French hospital tariffs for a drop of around 4% in the share price of Ramsay Healthcare, the Australian hospital group, which is one of the few international chains.
The French government announced private clinics would see a 2.5% decrease in tariffs, against a 1% decrease for public hospitals. Lamine Gharbi, president of the Fédération de l’Hôspitalisation Privée (FHP), and Yves Noël, the president of Santé-Cite group, explain the concerns of private clinics.
The European sale and leaseback healthcare property market grew by 33% in 2014, a new study by Your Care Consult reveals. We speak to Stéphane Pichon, managing director at Your Care, about the market and its prospects.
Philippe Charrier, CEO of Labco says the group is not interested in buying reference lab Biomnis before Labco floats. He says the long-awaited Labco IPO, slated for May 2015, should happen "before the summer."
Real estate investment trusts (REITs) are switching their portfolios from office to healthcare commercial properties. Lease terms of 25-30 years and yields of roughly 6% are an attractive offering in a growing market. Underlying growth drivers in healthcare ensure long-term demand for Opco, mitigating risk for the Propco.
Elderly care groups are expanding into new business models such as the step down market, homecare and domiciliary care to met the needs of Europe’s fast growing elderly population. Here we talk to policymakers, CEOs and academics about innovations and outline the five main trends: the personalisation of care, changes in payers attitude, a shift to homecare, and the emergence of an Eastern European market.
Medical gas producer Air Liquide has acquired majority stake in Optimal Medical Therapies (OMT), a German group specialising in home infusion therapy. We speak to Pascal Vinet, Head of Healthcare Global Operations, about the diversification of Air Liquide.
Two acquisitions have seen Orpea, Europe’s second largest residential care group, expand its homecare services and move into Austria and the Czech Reublic. It has bought ADHAP, the French domiciliary post-acute care specialist ADHAP and Austrian operator SeneCura. We spoke to Jean-Claude Marian, chairman at Orpea, about what’s next for the group.
PAI-backed Franco-Belgian lab group Cerba is to buy Novescia, the national French lab chain for €275m. We reflect on the deal and the state of the lab market.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
